HCC: Highlights from ASCO and WCGIC 2021

December 06, 2023 00:12:16
HCC: Highlights from ASCO and WCGIC 2021
COR2ED - Oncology Medical Conversation
HCC: Highlights from ASCO and WCGIC 2021

Dec 06 2023 | 00:12:16

/

Show Notes

In this episode, Dr Choo discusses some key abstracts presented during the virtual ASCO and WCGIC congresses in 2021.

Dr Choo comments that despite the promising and positive data with hepatic arterial infusion chemotherapy (HAIC) in two different Phase 3 trials settings, the impact on clinical practice is still questionable.

Dr Choo reviews some updated data from IMbrave150 which is the study that validated atezolizumab+bevacizumab combination as the new standard of care in 1L setting for aHCC patients. In addition, real-world data from OPTIMIS and GIDEON studies, confirmed that sorafenib has still a role to play in 1L specifically in Child-Pugh B patients.

Dr Choo emphasises that biomarkers are urgently needed in HCC and summarises several studies investigating potential biomarkers that would require further investigation prior to clinical practice validation.

Finally, Dr Choo completes the overview by presenting a Japanese study that provides support for radio frequency ablation as an option, apart from surgery for patients with small HCC.

Other Episodes

Episode

April 25, 2024 00:29:54
Episode Cover

Cáncer de próstata: dificultades en la fase preanalítica y pruebas de biomarcadores

¿Cuáles son los desafíos frecuentes en la fase preanalítica del cáncer de próstata, y cómo podemos superarlos? ¿Por qué es importante identificar las alteraciones...

Listen

Episode

December 06, 2023 00:19:56
Episode Cover

Multiple Myeloma: Choosing the best treatment regimen in patients with high-risk cytogenetics - Part 3

In this podcast episode, myeloma experts Dr. María Victoria Mateos (Haematologist at the University Hospital Salamanca, Spain) and Dr. Alexander Lesokhin (Associate Attending on...

Listen

Episode

December 06, 2023 00:29:25
Episode Cover

Advanced HCC: 2nd line treatment and the right time to switch

Prof. Dr Amit Singal, Gastroenterologist and Hepatologist at UT Southwestern Medical Center, USA and Prof. Dr Jeroen Dekervel, GI Oncologist at UZ Leuven, Belgium,...

Listen